Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...
Saved in:
| Main Authors: | Neal M Dixit, Shivani Shah, Boback Ziaeian, Gregg C Fonarow, Jeffrey J Hsu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-04-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2020.29 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
by: Nicholas K Brownell, et al.
Published: (2021-11-01) -
In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
by: Zachary L Cox, et al.
Published: (2022-06-01) -
Patient compliance and physicians’ adherence to guidelines on heart failure with reduced ejection fraction
by: V. N. Larina, et al.
Published: (2020-04-01) -
Guideline‐directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort
by: Natalia C. Berry, et al.
Published: (2025-06-01) -
Implementation of guideline‐directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa‐HF Registry)
by: Stefania Paolillo, et al.
Published: (2025-06-01)